(Q74251880)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9485247%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Abciximab and excessive bleeding in patients undergoing emergency cardiac operations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9485247%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

J S Gammie

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9485247%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

M Zenati

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9485247%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

R L Kormos

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9485247%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

B G Hattler

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9485247%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

L M Wei

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9485247%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

R V Pellegrini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9485247%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

B P Griffith

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9485247%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

C M Dyke

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9485247%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

language of work or name

English

0 references

publication date

1 February 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9485247%20AND%20SRC:MED&resulttype=core&format=json

The Annals of Thoracic Surgery

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9485247%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9485247%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9485247%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

465-469

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9485247%20AND%20SRC:MED&resulttype=core&format=json

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2897%2901299-X

Role of platelets in restenosis after percutaneous coronary revascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2897%2901299-X

A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2897%2901299-X

Monoclonal antibodies to platelet glycoprotein IIb/IIIa as antithrombotic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2897%2901299-X

Bleeding complications with the chimeric antibody to platelet glycoprotein IIb/IIIa integrin in patients undergoing percutaneous coronary intervention. EPIC Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2897%2901299-X

Hemorrhage and the use of blood products after adult cardiac operations: myths and realities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2897%2901299-X

Effect of platelet glycoprotein IIb/IIIa integrin blockade on activated clotting time during percutaneous transluminal coronary angioplasty or directional atherectomy (the EPIC trial). Evaluation of c7E3 Fab in the Prevention of Ischemic Complicatio

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2897%2901299-X

In vitro effects of the platelet glycoprotein IIb/IIIa receptor antagonist c7E3 Fab on the activated clotting time

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2897%2901299-X

Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker Integrelin in elective coronary intervention. IMPACT Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2897%2901299-X

EPILOG and CAPTURE trials halted because of positive interim results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2897%2901299-X

More evidence for a beneficial effect of platelet glycoprotein IIb/IIIa-blockade during coronary interventions. Latest results from the EPILOG and CAPTURE trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2897%2901299-X

10.1016/S0003-4975(97)01299-X

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9485247%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference